VX-973

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VX-973, covering 2024-05-06 to 2025-08-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Dose Escalation Study of VX-973 in Healthy Participants [Phase 1]